Utility of Renal Shift Tables to Assess the Magnitude and Chronicity of Antibiotic-Associated Changes in Renal Function in Clinical Trials: Results From Assessment of Telavancin for Treatment of Hospital-Acquired Pneumonia (ATTAIN) Trials for Telavancin and Vancomycin

Journal article

Peer reviewed

Boris Nogid, Thomas Hardin, Melinda Lacy, Claire Sherman, Lee Morrow, Jamie Dwyer, Kieren A. Marr, Steven Barriere and Jon Bruss

Open forum infectious diseases, Vol.3(suppl_1)

12/01/2016

Metrics

4 Record Views

Title: Utility of Renal Shift Tables to Assess the Magnitude and Chronicity of Antibiotic-Associated Changes in Renal Function in Clinical Trials: Results From Assessment of Telavancin for Treatment of Hospital-Acquired Pneumonia (ATTAIN) Trials for Telavancin and Vancomycin
Creators: Boris Nogid - Theravance Biopharma
Thomas Hardin - Theravance Biopharma
Melinda Lacy - Theravance Biopharma
Claire Sherman - Theravance Biopharma
Lee Morrow - Creighton University
Jamie Dwyer - Vanderbilt University Medical Center
Kieren A. Marr - Johns Hopkins Hospital
Steven Barriere - Theravance, Inc., South San Francisco, California
Jon Bruss - Theravance Biopharma
Publication Details: Open forum infectious diseases, Vol.3(suppl_1)
Identifiers: 991005970167302656
Academic Unit: Pulmonary and Critical Care
Language: English
Resource Type: Journal article